Compare Danaher Corporation (DHR) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Teucrium Soybean Fund — how do they compare? Danaher Corporation trades at $201.11 (market cap $140.88B), while Teucrium Soybean Fund trades at $25.44. The key difference: Danaher Corporation pays a 0.8% dividend while Teucrium Soybean Fund pays none, and Teucrium Soybean Fund is trading nearer its 52-week high, Danaher Corporation nearer its low. Which is the better fit depends on your goals.
| DHR | SOYB | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $242.05 | $25.36 |
52-Week Low | $161.91 | $21.07 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
SOYB trades at $25.33, up 0.64% on the day, with a bullish technical outlook from moving averages but neutral oscillators. The stock lacks disclosed financial ratios, and recent news highlights potential tailwinds from agricultural trade developments, including China's pledge to buy $17 billion of U.S. crops annually through 2028, which could benefit related sectors.
The stock's upside is supported by positive technical momentum and sector-specific catalysts, though the absence of fundamental data limits valuation clarity. Risks include reliance on agricultural market stability and potential volatility from commodity price swings, requiring careful assessment of upcoming earnings and guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
